Proofs of the structure of lipid coated nanoparticles (SMBV(TM)) used as drug carriers

Pharmaceutical Research

Volumn 17, Issue 7, 2000, Pages 817-824

  De Miguel, Ignacio ^a   Imbertie, Laurent ^a   Rieumajou, Valerie ^a   Major, Michel ^a   Kravtzoff, Roger ^a   Betbeder, Didier ^a  

^a Biovector Therapeutics   (France)

Author keywords

Characterisation; Fluorescence; Liposome; Microscopy; Supramolecular biovector; Zeta potential

Indexed keywords

CATION; CHOLESTEROL; DRUG CARRIER; LIPID; LIPOSOME; NANOPARTICLE; PHOSPHOLIPID; POLYSACCHARIDE;

ARTICLE; DEVICE; DRUG DELIVERY SYSTEM; LIPID MEMBRANE; MEMBRANE STRUCTURE; MOLECULAR INTERACTION; PARTICLE SIZE; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; CAPSULES; CHOLESTEROL; DRUG CARRIERS; LIPOSOMES; POLYSACCHARIDES;

EID: 0033839309     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007504124603     Document Type: Article

References (25)

1. Characterisation and phase behaviour of phospholipide bilayers adsorbed on spherical polysaccharide nanoparticles
2. Supramolecular Biovectors (SMBV(TM)) improve antisense inhibition of erbB-2 expression
3. Improved oligonucleotide uptake and stability by a new drug carrier, the Supramolecular Biovector (SMBV(TM))
4. Conjugates of a particle vector and oligonucleotides, process for their preparation and pharmaceutical compositions containing them. PCT WO 98/29557
5. Stabilization and enhancement of interleukine-2 in vitro bioactivity by new carriers: Supramolecular Biovectors
6. A new family of carriers (Biovectors) enhances the immunogenicity of rabies antigens
7. Nasal residence time evaluation of cationic Biovector in human volunteers
8. Mucosal administration of substances to mammals. PCT WO 98/29099
9. Combination of human cytomegalovirus recombinant immediate-early protein (IE1) with 80 nm cationic Biovectors: Protection from proteolysis and potentiation of presentation to CD4+ T-Cell clones in vitro
10. Biovector loaded with a trivalent split influenza vaccine administered intranasally induce a strong mucosal and seric response in mice
11. Method for enhancing immunogenicity, product obtained and pharmaceutical composition. PCT WO 96/06638
12. Structural characterisation (shape and dimensions) and stability of polysaccharide/lipid nanoparticles
13. Structural characterisation of organized systems of polysaccharides and phospholipids by light scattering spectroscopy and electron microscopy
14. Solid core liposomes with encapsulated gold particles
15. Lipobeads: A hydrogel anchored lipid vesicle system
16. Synthesis and characterization of Supramolecular Biovectors (SMBV(TM)) specifically designed for the entrapment of ionic molecules
17. Particulate vector useful for the transport of molecules with biological activity and process for its preparation. Eur. Pat. EP 344040 (PCT WO89/11271)
18. Characterisation of colloidal drug carrier systems with zeta potential measurements
19. Temperature and ionic strength-induced conformational changes in the lipid head group region of liposomes as suggested by zeta potential data
20. Molecular architecture and function of polymeric oriented systems: Models for the study of organisation, surface recognition, and dynamics of biomembranes
21. Integrity of mixed liposomes contacting a polycation depends on the negatively charged lipid content
22. The surface properties of phospholipid liposome systems and their characterisation
23. Use of resonance energy transfer to monitor membrane fusion
24. Monitoring of phospholipid vesicle fusion by fluorescence energy transfer between membrane-bound dye labels
25. Surface density determination in membranes by fluorescence energy transfer